is glp-1 bad #ADAICYMI: What “Ozempic Tongue”? It’s a term for the persistent taste in the mouth that some users of drugs experience. While there isn’t a definitive reason for this side effect, dry Weight loss with GLP-1 medications

Severe bloating, persistent vomiting, or failure to pass stool or gas , which may indicate bowel obstruction or severe gastroparesis

Patients' sleep-wake patterns and activity index were assessed by a 7-day actigraph covering the second week of each treatment schedule

In Study 1, we found that participants evaluated an individual who lost weight with a GLP-1 more harshly than an individual who lost weight via diet and exercise (i.e., higher in negative traits, lower in positive traits, more unhealthy, less willing to affiliate)

Immunovant Sector: Pharmaceuticals and biotechnology (autoimmune and immunology therapeutics) HQ: 320 W 37th St., New York, NY Year Founded: 2018 Key Leaders: Eric Venker, MD, PharmD, CEO Number of Employees: 362 Stage: Public Financial Snapshot: $3.83 billion Notable Investors: SG Americas Securities, Roivant Sciences, RTW Investments, and BVF Partners Key Products: Immunovant is developing Batoclimab, an FcRn-targeting monoclonal antibody for autoimmune diseases (MG, TED, Graves disease), which is in Phase 3 registrational trials

The antioxidant is generally found in the liver as it attaches itself to the toxins that flow through the liver and takes them out of the body